Clinical validation of serum endocan (ESM-1) as a potential biomarker in patients with renal cell carcinoma

To determine the suitability of serum endocan (ESM-1) levels for diagnosing and monitoring renal cell carcinoma (RCC), we measure serum ESM-1 levels in 56 RCC patients who had undergone radical or partial nephrectomies and 56 age- and sex-matched healthy kidney donors. Measurements were made before...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kwang Hyun, Lee, Hyung Ho, Yoon, Young Eun, Na, Joon Chae, Kim, Sook Young, Cho, Young In, Hong, Sung Joon, Han, Woong Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787497/
https://www.ncbi.nlm.nih.gov/pubmed/29416643
http://dx.doi.org/10.18632/oncotarget.23087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787497/
https://www.ncbi.nlm.nih.gov/pubmed/29416643
http://dx.doi.org/10.18632/oncotarget.23087

Ejemplares similares